Box office
Moviesfera Newsroom
Box office

A $35.7B box office is great news, but it's not a healthy one

Gower Street's near-$36 billion forecast is a headline win for 2026, but the rebound leans on a few event films and local hits, not a thriving middle class.

Published
October 30, 2026
Reading time
4 min
Categories
Box office

AI-generated image

Is a box office a healthy one if it takes a billion-dollar blockbuster to make the average release look normal? That's the question hiding behind the celebratory headline. Theaters are back, we're told. Back for whom?

The headline number is real enough. As Deadline reports, Gower Street Analytics has raised its 2026 global ticket-sales forecast to $35.7 billion, up 2.9% from its previous estimate, reported in April. Nobody serious should sneer at that.

But a total is an average of winners and losers, and 2026 has been very generous to the winners.

The top of the chart is doing the heavy lifting

By August, according to Khaleej Times, the global box office had already produced four billion-dollar hits. Variety, as cited by Comic Basics, singles out The Super Mario Galaxy Movie ($110 million budget) and Michael ($155 million budget), both past $1 billion worldwide. Bloomberg's own take on the year credits Spider-Man and the Odyssey films with driving the revival.

Those are wonderful stories, and they prove something we've argued for a while: audiences will still leave the house for an event. But an event is not a habit. A recovery that depends on a handful of must-see titles is a recovery with a very short bench. If two or three of those films had slipped a year, we suspect the forecast would read very differently.

The middle class of movies is still missing

Now look at the other end of the spectrum. Klara and the Sun, with a Kazuo Ishiguro story, a Taika Waititi script and a cast that includes Jenna Ortega, Amy Adams and Natasha Lyonne, opened to just over $700,000, MovieWeb reports. It was initially set for more than 1,900 U.S. theaters and was scaled back to 880 after poor early reviews (a 25% critic score on Rotten Tomatoes at the time of reporting). Sony Pictures then pulled the Spanish release, according to the Spanish outlet Hobby Consolas.

One flop proves nothing, and critics' reception is part of this story. Still, it illustrates the gap we worry about. The adult, author-driven film, the kind that used to fill the space between a franchise tentpole and a micro-budget genre picture, seems to get very little room to find its audience once the early reviews are bad. In a year when the top is this tall, the floor feels lower, not higher. The financial press loves a rising tide, but this tide looks like it's lifting yachts.

There are encouraging counterexamples: Financial Express points to sleeper hits such as Obsession, and to a $368 million horror in its headline. Those are welcome. But two sleepers don't make a middle class, and we'd want to see far more of them before declaring the in-between film healthy.

Hollywood isn't the only one winning

The other uncomfortable detail for the "Hollywood is back" narrative is geography. Celluloid Junkie notes that the international recovery in the first half of 2026 was led by gains across Europe, Asia and Australia, "even as local films often outpaced Hollywood." Look at India, where, per Hindustan Times, Jailer 2 had brought in ₹431 crore by day 16.

That's good news for cinema as an art form and for the global exhibition business. It's more awkward for any studio executive reading a record-chasing total as a vindication of the old Hollywood model. A recovery spread across local-language hits, a few global franchises and a couple of cultural-moment films is, in our view, a different industry than the pre-pandemic one: more fragmented and harder to forecast.

Our verdict: celebrate the number, distrust the story

Take the $35.7 billion with a grain of salt; it's a forecast, and forecasts get revised, as this one was. What we'd resist is the lazy conclusion that theaters are simply "fixed." What's been fixed, it seems, is the top end. The real test of a healthy box office is whether a thoughtful, non-franchise film can find its audience before it gets pulled from half its screens.

If studios read this year as proof that event films are all that matter, they'll make even fewer of the movies that give a theatrical year its depth. If they read it as proof that people still want a reason to go, there's hope. Our advice to distributors: give the in-between films a real runway. Our advice to moviegoers: the best way to keep the in-between alive is to buy a ticket for it, not just for the billion-dollar one.

Debate topics

No topics yet: start the first one.

More stories